TB CAB

Advocates, alarmed by appalling global response to MDR-TB outbreak in Papua New Guinea, call on international agencies to take action

Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.

Read More →

Urgent need to scale up access to new treatment options for MDR-TB in the Philippines

Given the urgent need to address the MDR-TB epidemic in the Philippines, advocates urge for rapid delivery of the new treatment options to people with MDR-TB.

Read More →

Appeal to develop VXc-486 for tuberculosis

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.

Read More →

ACTION ALERT: Urge Johns Hopkins University to accelerate important TB innovation & keep it accessible for all

Take Action for TB Today! Sign and share this petition now: https://uaem.wufoo.com/forms/z1dxtbgq0ieib3a/

Read More →

TB community reiterates request to Johns Hopkins to review sutezolid licensing agreement with Sequella

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Read More →

Open letter to WHO: Recording and reporting of preventive TB therapy in children

Members of the global childhood TB community respond to the World Health Organization requesting additions to the End TB Strategy list of priority indicators related to the monitoring and evaluation of treatment for latent TB infection in children.

Read More →

Letter from TB community re: intellectual property rights to sutezolid

The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.

Read More →

TB CAB, TAG open letter to the Global Plan Development Task Force

Re: Programmatic and research targets for the Global Plan to Stop TB, 2016–2020

Read More →

Open Letter to WHO: Time to report preventive TB therapy for children

On World TB Day, members of the global childhood TB community sent an open letter to the World Health Organization requesting they include the number of children under the age of five and the number of children with HIV started on preventive TB therapy in the annual Global Tuberculosis Report by 2016.

Read More →

Public comments to be considered by the Expert Committee on the Selection and Use of Essential Medicines at the World Health Organization

Community groups sent public comments in support of the addition of rifapentine, delamanid, bedaquiline and linezolid to the WHO Model List of Essential Medicines.

Read More →

Page 2 of 4 · Total posts: 10

←First 1 2 3 Last→